Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Tarceva

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Tarceva was produced by Roche and Astellas.

AZ’s Tagrisso cuts risk of EGFR-positive NSCLC spreading to the brain

AZ’s Tagrisso cuts risk of EGFR-positive NSCLC spreading to the brain

including AZ’s own Iressa (gefitinib) and Roche’s Tarceva (erlotinib).

J&J’s bispecific lung cancer antibody nabs FDA breakthrough status

J&J’s bispecific lung cancer antibody nabs FDA breakthrough status This type of mutation occurs in tumours that aren’t sensitive to treatment with first- and second-generation small-molecule EGFR inhibitors like AstraZeneca’s Iressa (gefitinib), Roche’s Tarceva (erlotinib)

Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC

Lilly’s Cyramza narrowly clears FDA adcomm vote for first-line NSCLC That study evaluated Cyramza alongside Roche’s Tarceva (erlotinib), where it demonstrated media progression-free survival of 19.4 months, compared to 12.4 months in the placebo-plus-Tarceva arm. ... Tarceva “is associated with increased toxicity

Tagrisso tops rival drugs on survival in first-line lung cancer

Tagrisso tops rival drugs on survival in first-line lung cancer The improvement in OS came over other drugs in the EGFR inhibitor class, namely AZ’s own Iressa (gefitinib) and Roche’s Tarceva (erlotinib), and according to AZ’s head of

AstraZenca to appeal NICE rejection of Tagrisso

AstraZenca to appeal NICE rejection of Tagrisso NICE agreed that Tagrisso extends progression-free (PFS) and overall survival (OS) compared with first generation EGFR-targeting drugs Iressa and Tarceva, but said the size of the benefit is unclear.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....